ישראל - עברית - Ministry of Health

taro international ltd, israel - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 100 mg - erlotinib

ישראל - עברית - Ministry of Health

taro international ltd, israel - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 150 mg - erlotinib

ישראל - עברית - Ministry of Health

taro international ltd, israel - erlotinib as hydrochloride - טבליות מצופות פילם - erlotinib as hydrochloride 25 mg - erlotinib

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - epoprostenol as sodium - אבקה להכנת תמיסה לאינפוזיה - epoprostenol as sodium 1.5 mg/vial - epoprostenol - epoprostenol - flolan is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - epoprostenol as sodium - אבקה להכנת תמיסה לאינפוזיה - epoprostenol as sodium 0.5 mg/vial - epoprostenol - epoprostenol - flolan is indicated for the long-term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - treprostinil as sodium - תמיסה להזרקה - treprostinil as sodium 5 mg/ml - treprostinil - treprostinil - remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. pulmonary hypertension associated with congenital systemic to pulmonary shunts.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - treprostinil as sodium - תמיסה להזרקה - treprostinil as sodium 2.5 mg/ml - treprostinil - treprostinil - remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. pulmonary hypertension associated with congenital systemic to pulmonary shunts.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - treprostinil as sodium salt - תמיסה לשאיפה - treprostinil as sodium salt 1.74 mg / 2.9 ml - treprostinil - treprostinil - treatment of pulmonary arterial hypertension in patients with nyha class iii symptoms, to increase walk distance.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ambrisentan - טבליות מצופות פילם - ambrisentan 5 mg - ambrisentan - volibris is indicated for the treatment of patients with pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity . efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ambrisentan - טבליות מצופות פילם - ambrisentan 10 mg - ambrisentan - volibris is indicated for the treatment of patients with pulmonary arterial hypertension (pah) classified as who functional class ii and iii, to improve exercise capacity . efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.